Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Disease - O'Gorman, J; Chiao, P; Bussière, T (The journal of prevention of Alzheimer's disease, 2017)
et al.